Participant flow36

How many started, completed or left each group, period by period.

1 to 20 of 36

Period	Milestone	Group	Participants
Cohort 1	STARTED	NTx®-265 Low Dose	24
Cohort 1	STARTED	NTx®-265 Medium Dose	0
Cohort 1	STARTED	NTx®-265 High Dose	0
Cohort 1	STARTED	Placebo	8
Cohort 1	COMPLETED	NTx®-265 Low Dose	22
Cohort 1	COMPLETED	NTx®-265 Medium Dose	0
Cohort 1	COMPLETED	NTx®-265 High Dose	0
Cohort 1	COMPLETED	Placebo	6
Cohort 1	NOT COMPLETED	NTx®-265 Low Dose	2
Cohort 1	NOT COMPLETED	NTx®-265 Medium Dose	0
Cohort 1	NOT COMPLETED	NTx®-265 High Dose	0
Cohort 1	NOT COMPLETED	Placebo	2
Cohort 2	STARTED	NTx®-265 Low Dose	0
Cohort 2	STARTED	NTx®-265 Medium Dose	24
Cohort 2	STARTED	NTx®-265 High Dose	0
Cohort 2	STARTED	Placebo	8
Cohort 2	COMPLETED	NTx®-265 Low Dose	0
Cohort 2	COMPLETED	NTx®-265 Medium Dose	18
Cohort 2	COMPLETED	NTx®-265 High Dose	0
Cohort 2	COMPLETED	Placebo	6

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00938314/flow